Skip to main content
SpringerLink
Log in

Hypoglykämie

Klassifikation, Therapie und vermeidbare Fehler

  • Schwerpunkt: Endokrine und metabolische Krisen
  • Published:
Der Internist Aims and scope Submit manuscript

Zusammenfassung

Die Problematik von Hypoglykämien umfasst ein multifaktorielles Geschehen, bei dem physiologische Parameter und das Verhalten der betroffenen Patienten im Rahmen der Selbstkontrolle miteinender interagieren. Insbesondere die zunehmende Therapie mit Insulin und nahe-normoglykämische Blutglukoseeinstellung haben die Hypoglykämie zu einem bedeutenden Problem im Rahmen der diabetesbedingten Akutkomplikationen werden lassen. Eine frühzeitige Diagnostik und Therapieeinleitung sind daher unerlässlich um die erhöhte Mortalität zu senken. Neben der Akuttherapie der Hypoglykämie umfassen die erweiterten therapeutischen Maßnahmen die Modifikation der Diabetestherapie, Patientenschulungen sowie ein spezielles Hypoglykämiewahrnehmungstraining.

Abstract

Hypoglycemia is a multifactorial problem that is caused by the interaction of numerous variables such as a individual pathophysiological response, treatment aspects and self control. In particular, the increasing use of intensified insulin therapy and thus the goal of normoglycemia has made hypoglycaemia to become a major hazard among the acute complications of diabetes mellitus. Early diagnosis and treatment is thus mandatory to reduce the increased morbidity and mortality of hypoglycaemia. Among the acute therapy of hypoglycaemia treatment includes a modification of diabetes therapy, patient education and a special training of hypoglycaemia awareness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1.

Literatur

  1. Laing SP, Swerdlow AJ, Slater SD et al. (1999) The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 16: 466–471

    CAS  PubMed  Google Scholar 

  2. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986

    PubMed  Google Scholar 

  3. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837–853

    PubMed  Google Scholar 

  4. Cryer PE (2002) Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia 45: 937–948

    Article  Google Scholar 

  5. Johnson ES, Koepsell TD, Reiber G, Stergachis A, Platt R (2002) Increasing incidence of serious hypoglycemia in insulin users. J Clin Epidemiol 55: 253–259

    Article  PubMed  Google Scholar 

  6. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J (1993) Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 42: 1233–1237

    CAS  Google Scholar 

  7. Heller SR, Cryer PE (1991) Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 40: 223–226

    CAS  PubMed  Google Scholar 

  8. U.K. Prospective Diabetes Study Group (1995) U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 44: 1249–1258

    PubMed  Google Scholar 

  9. Leese GP, Wang J, Broomhall J et al. (2003) Freyuency of severe hyperglycemia requiring emergency treatment in type 1 and type 2 diabetes. Diabetes Care 26: 1176–1180

    Google Scholar 

  10. Levy CJ, Kinsley BT, Bajaj M, Simonson DC (1998) Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM. Diabetes Care 21: 1330–1338

    CAS  Google Scholar 

  11. Stiefelhagen P (2002) Hypoglycemia risk. Why elderly patients are especially at risk. MMW Fortschr Med 144: 10

    CAS  Google Scholar 

  12. Baker D, Evans M, Cryer P, Sherwin R (1997) Hypoglycaemia and glucose sensing. Diabetologia 40: B83–B88

    Article  PubMed  Google Scholar 

  13. Bolli GB, Pampanelli S, Porcellati F, Fanelli CG (2002) Recovery and prevention of hypoglycaemia unawareness in type 1 diabetes mellitus. Diabetes Nutr Metab 15: 402–409

    CAS  Google Scholar 

  14. Hermanns N, Kulzer B, Maier B, Kubiak T, Haak T (2002) Risikoindikatoren für das Auftreten schwerer Hypoglykämien bei Patienten mit Typ-1-Diabetes mellitus. Diabetes Stoffw 11: 145–149

    Google Scholar 

  15. Muhlhauser I, Overmann H, Bender R, Bott U, Berger M (1998) Risk factors of severe hypoglycaemia in adult patients with Type I diabetes—a prospective population based study. Diabetologia 41: 1274–1282

    CAS  PubMed  Google Scholar 

  16. Allen C, LeCaire T, Palta M et al. (2001) Risk factors for frequent and severe hypoglycemia in type 1 diabetes. Diabetes Care 24: 1878–1881

    CAS  PubMed  Google Scholar 

  17. Cryer PE, Davis SN, Shamoon H (2003) Hypoglycemia in diabetes. Diabetes Care 26: 1902–1912

    CAS  PubMed  Google Scholar 

  18. Cryer PE (2002) The pathophysiology of hypoglycaemia in diabetes. Diabetes Nutr Metab 15: 330–333

    CAS  Google Scholar 

  19. Heller SR (1999) Diabetic hypoglycaemia. Baillieres Best Pract Res Clin Endocrinol Metab 13: 279–294

    Article  CAS  PubMed  Google Scholar 

  20. Lobmann R, Lehnert H. (1997) Notfallsituation Hypoglykämie. Notfallmedizin 510–513

  21. Holstein A, Plaschke A, Schlieker H, Egberts EH (2002) Structural and process quality in the management of diabetic emergencies in Germany. Int J Qual Health Care 14: 33–38

    Article  CAS  PubMed  Google Scholar 

  22. McAulay V, Deary IJ, Frier BM (2001) Symptoms of hypoglycaemia in people with diabetes. Diabetes Med 18: 690–705

    CAS  Google Scholar 

  23. Del Prato S, Aragona M, Coppelli A (2002) Sulfonylureas and hypoglycaemia. Diabetes Nutr Metab 15: 444–450

    PubMed  Google Scholar 

  24. Gold AE, MacLeod KM, Frier BM (1994) Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 17: 697–703

    CAS  PubMed  Google Scholar 

  25. Clarke WL, Gonder-Frederick LA, Richards FE, Cryer PE (1991) Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Association with defective glucose counterregulation and better glycemic control. Diabetes 40: 680–685

    CAS  Google Scholar 

  26. Heller SR, Amiel SA, Mansell P (1999) Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group. Diabetes Care 22: 1607–1611

    CAS  Google Scholar 

  27. Brunelle BL, Llewelyn J, Anderson JH, Gale EA, Koivisto VA (1998) Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 21: 1726–1731

    CAS  PubMed  Google Scholar 

  28. Home PD, Lindholm A, Hylleberg B, Round P (1998) Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group. Diabetes Care 21: 1904–1909

    CAS  Google Scholar 

  29. Ratner RE, Hirsch IB, Neifing JL et al. (2000) Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care 23: 639–643

    CAS  Google Scholar 

  30. Yki-Jarvinen H, Dressler A, Ziemen M (2000) Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group. Diabetes Care 23: 1130–1136

    CAS  Google Scholar 

  31. Hermansen K, Madsbad S, Perrild H, Kristensen A, Axelsen M (2001) Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy. Diabetes Care 24: 296–301

    CAS  Google Scholar 

  32. Holstein A, Plaschke A, Egberts EH (2001) Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide. Diabetes Metab Res Rev 17: 467–473

    Article  CAS  PubMed  Google Scholar 

  33. Holstein A, Plaschke A, Hammer C, Egberts EH (2003) Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia. Eur J Clin Pharmacol 59: 91–97

    CAS  Google Scholar 

  34. Klein J, Ott V, Schutt M, Klein HH (2002) Recurrent hypoglycaemic episodes in a patient with Type 2 diabetes under fibrate therapy. J Diabetes Complications 16: 246–248

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Endokrinologie und Stoffwechselkrankheiten, Universität Magdeburg

    R. Lobmann & H. Lehnert

  2. Klinik für Endokrinologie und Stoffwechselkrankheiten, Zentrum für Innere Medizin der Otto-von-Guericke Universität Magdeburg, Leipziger Straße 44, 39120, Magdeburg

    R. Lobmann

Authors
  1. R. Lobmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Lehnert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Lobmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lobmann, R., Lehnert, H. Hypoglykämie. Internist 44, 1275–1282 (2003). https://doi.org/10.1007/s00108-003-1052-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-003-1052-z

Schlüsselwörter

Keywords

Search

Navigation